Adagrasib and Amisulpride: Interaction Details
- Adagrasib
- Krazati
- Amisulpride
- Barhemsys
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Adagrasib and Amisulpride interaction:
Amisulpride
- Barhemsys
We don't have a drug information page for Amisulpride yet. Have a question about Amisulpride? Ask a pharmacist, free →
What Happens When You Take Adagrasib With Amisulpride
What can happen when they are taken together (rated Major)
An increased risk of , , polymorphic ventricular , other serious
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Adagrasib should not be combined with other products known to have the potential to prolong the . Adagrasib itself prolongs the QTc interval, and giving it together with other QTc-prolonging products may produce a larger increase in the QTc interval, along with adverse reactions linked to that prolongation, such as torsade de pointes, other serious arrhythmias, and sudden death.
An and electrolytes should be checked before adagrasib is started and during , and again as clinically indicated, in patients with congestive heart failure, bradyarrhythmias, or electrolyte abnormalities, and in those who cannot avoid medications known to prolong the . If the QTc interval exceeds 500 msec, or the change from baseline exceeds 60 msec, adagrasib should be withheld until the QTc interval falls below 481 msec or returns to baseline, and then restarted at the next lower dose level. Adagrasib should be permanently discontinued if torsade de pointes, polymorphic ventricular tachycardia, or signs or symptoms of a serious or life-threatening arrhythmia occur.1
The Adagrasib and Amisulpride Interaction, Explained
Adagrasib (Krazati) is a cancer medicine that can slightly lengthen the time your heart takes to recharge between beats, something doctors call the . Amisulpride (Barhemsys) is given for nausea and vomiting after surgery, and it can do the same thing. Taking them together could add up and raise the chance of a serious heart rhythm problem.
This risk is mostly based on how the drugs work, not on many reported cases. Amisulpride for nausea is usually given as a single dose in a medical setting, so your team can plan around it. Please tell your surgical team and pharmacist that you take Krazati. They may check your heart tracing and your potassium and magnesium levels. Don't change any medicine on your own.
(). Both adagrasib and amisulpride prolong the . Combined use may increase the risk of , polymorphic VT, other serious , and sudden death. Evidence is theoretical, with no specific clinical study documented for this pair. Onset is unspecified. Severity is rated major.
- Avoid where possible.
- If unavoidable, obtain an and electrolytes (especially K and Mg) at baseline, during co-use, and as clinically indicated, particularly with CHF, bradyarrhythmias, or electrolyte abnormalities.
- Withhold adagrasib if QTc is above 500 msec or the change from baseline is above 60 msec, until QTc is below 481 msec or back to baseline. Resume at the next lower dose level.
- Permanently discontinue adagrasib for torsade, polymorphic VT, or signs of serious arrhythmia.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Adagrasib and Amisulpride Interact
The likely mechanism
How to Manage the Adagrasib and Amisulpride Interaction
Your care team's usual first step is to avoid using these two medicines together when possible. If you need both, they can manage it with careful monitoring.
- Your team may check an and blood levels of potassium and magnesium before and during treatment.
- Your Krazati dose may need to be paused or adjusted and individualized by your care team if your ECG shows a significant change.
- Keep taking your medicines as prescribed unless your team tells you otherwise.
- Tell your pharmacist and surgical or anesthesia team about all your medicines.
- Seek help right away for fainting, a racing or irregular heartbeat, or severe dizziness.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Adagrasib or Amisulpride need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Adagrasib and Amisulpride: Common Questions
How serious is the Adagrasib and Amisulpride interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Adagrasib and Amisulpride interaction managed?
Your care team's usual first step is to avoid using these two medicines together when possible. If you need both, they can manage it with careful monitoring. Your team may check an and blood levels of potassium and magnesium before and during treatment. Your Krazati dose may need to be paused or adjusted and individualized by your care team if your ECG shows a significant change. Keep taking y… Management is individual — always follow your own care team's guidance.
Who is at higher risk from the Adagrasib and Amisulpride interaction?
The interaction record names these groups as more likely to be affected:
- People with low potassium or magnesium
- People with heart disease or heart failure
If this describes you, tell your pharmacist or prescriber.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Adagrasib and Amisulpride Interaction
Ask in your own words about taking Adagrasib and Amisulpride together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: KRAZATI(TM) oral tablets, adagrasib oral tablets. Mirati Therapeutics Inc (per FDA), San Diego, CA, 2024. DailyMed
Other Serious Interactions of Adagrasib and Amisulpride
Also serious with Adagrasib
- DeuruxolitinibContraindicated
- Dihydroergotamine InjectionContraindicated
- Dihydroergotamine Nasal SprayContraindicated
- FinerenoneContraindicated
Also serious with Amisulpride
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Adagrasib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- WineMajor
- American HelleboreMajor
- ArsenicMajor
- BeerMajor
- CesiumMajor
- + 174 more
With Amisulpride
- GrapefruitMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- Bitter OrangeModerate
- CinchonaModerate
- + 5 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.